Fujimaki K, Jambhekar A, Lahav G
bioRxiv. 2025; .
PMID: 39990415
PMC: 11844538.
DOI: 10.1101/2025.02.14.638318.
Longhurst A, Wang K, Suresh H, Ketavarapu M, Ward H, Jones I
Elife. 2025; 13.
PMID: 39903505
PMC: 11793871.
DOI: 10.7554/eLife.97577.
Funk A, Katerji M, Afifi M, Nyswaner K, Woodroofe C, Edwards Z
bioRxiv. 2024; .
PMID: 39605563
PMC: 11601640.
DOI: 10.1101/2024.11.19.623840.
Purzner J, Brown A, Purzner T, Ellis L, Broski S, Litzenburger U
bioRxiv. 2024; .
PMID: 39605517
PMC: 11601632.
DOI: 10.1101/2024.11.21.624171.
Daigh L, Saha D, Rosenthal D, Ferrick K, Meyer T
Nat Commun. 2024; 15(1):9181.
PMID: 39448567
PMC: 11502682.
DOI: 10.1038/s41467-024-52820-6.
The G-S transition is promoted by Rb degradation via the E3 ligase UBR5.
Zhang S, Valenzuela L, Zatulovskiy E, Mangiante L, Curtis C, Skotheim J
Sci Adv. 2024; 10(43):eadq6858.
PMID: 39441926
PMC: 11498223.
DOI: 10.1126/sciadv.adq6858.
Quiescent cancer cells induced by high-density cultivation reveals cholesterol-mediated survival and lung metastatic traits.
Liu X, Min Q, Cheng X, Zhang W, Wu Q, Chen X
Br J Cancer. 2024; 131(10):1591-1604.
PMID: 39390252
PMC: 11555385.
DOI: 10.1038/s41416-024-02861-x.
Lineage-specific CDK activity dynamics characterize early mammalian development.
Saykali B, Tran A, Cornwell J, Caldwell M, Rezvan Sangsari P, Morgan N
bioRxiv. 2024; .
PMID: 39372752
PMC: 11451597.
DOI: 10.1101/2024.06.14.599098.
Nonclinical characterization of ICVB-1042 as a selective oncolytic adenovirus for solid tumor treatment.
Kato Y, Rice N, Pokrass M, Jeong J, Rodriguez R, Field J
Commun Biol. 2024; 7(1):1132.
PMID: 39271928
PMC: 11399272.
DOI: 10.1038/s42003-024-06839-6.
Excitable Rho dynamics control cell shape and motility by sequentially activating ERM proteins and actomyosin contractility.
Marshall-Burghardt S, Migueles-Ramirez R, Lin Q, El Baba N, Saada R, Umar M
Sci Adv. 2024; 10(36):eadn6858.
PMID: 39241071
PMC: 11378911.
DOI: 10.1126/sciadv.adn6858.
Quiescence-Origin Senescence: A New Paradigm in Cellular Aging.
Yao G
Biomedicines. 2024; 12(8).
PMID: 39200301
PMC: 11351160.
DOI: 10.3390/biomedicines12081837.
An image-based screen for secreted proteins involved in breast cancer G0 cell cycle arrest.
Weston W, Holt J, Wiecek A, Pilling J, Schiavone L, Smith D
Sci Data. 2024; 11(1):868.
PMID: 39127790
PMC: 11316812.
DOI: 10.1038/s41597-024-03697-z.
APC/C prevents a noncanonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest.
Mouery B, Baker E, Mei L, Wolff S, Mills C, Fleifel D
Proc Natl Acad Sci U S A. 2024; 121(30):e2319574121.
PMID: 39024113
PMC: 11287123.
DOI: 10.1073/pnas.2319574121.
An intermediate Rb-E2F activity state safeguards proliferation commitment.
Konagaya Y, Rosenthal D, Ratnayeke N, Fan Y, Meyer T
Nature. 2024; 631(8020):424-431.
PMID: 38926571
PMC: 11236703.
DOI: 10.1038/s41586-024-07554-2.
Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery.
Lu K, Zhou X
Sci Signal. 2024; 17(841):eadi8743.
PMID: 38889227
PMC: 11409840.
DOI: 10.1126/scisignal.adi8743.
The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia.
Zheng R, Wei W, Liu S, Zeng D, Yang Z, Tang J
Cell Commun Signal. 2024; 22(1):314.
PMID: 38849885
PMC: 11157785.
DOI: 10.1186/s12964-024-01694-8.
CDK4/6 activity is required during G arrest to prevent stress-induced endoreplication.
McKenney C, Lendner Y, Guerrero Zuniga A, Sinha N, Veresko B, Aikin T
Science. 2024; 384(6695):eadi2421.
PMID: 38696576
PMC: 11305671.
DOI: 10.1126/science.adi2421.
Sustained ERK signaling promotes G2 cell cycle exit and primes cells for whole-genome duplication.
Guerrero Zuniga A, Aikin T, McKenney C, Lendner Y, Phung A, Hook P
Dev Cell. 2024; 59(13):1724-1736.e4.
PMID: 38640927
PMC: 11233237.
DOI: 10.1016/j.devcel.2024.03.032.
Reciprocal antagonism of PIN1-APC/C governs mitotic protein stability and cell cycle entry.
Ke S, Dang F, Wang L, Chen J, Naik M, Li W
Nat Commun. 2024; 15(1):3220.
PMID: 38622115
PMC: 11018817.
DOI: 10.1038/s41467-024-47427-w.
The PRC2.1 Subcomplex Opposes G1 Progression through Regulation of CCND1 and CCND2.
Longhurst A, Wang K, Suresh H, Ketavarapu M, Ward H, Jones I
bioRxiv. 2024; .
PMID: 38562687
PMC: 10983909.
DOI: 10.1101/2024.03.18.585604.